"
Clinical Characteristics of Japanese Type 2 Diabetic Patients Responsive to Sitagliptin"
written by Kouichi Inukai, Takumi Hirata, Takashi Sumita, Masaki Watanabe, Yuichi Ikegami, Daisuke Ito, Susumu Kurihara, Nobuyuki Yasukawa, Jiro Morimoto, Nobuki Takata, Kenta Kanazawa, Tamotsu Neda, Yoshikazu Sumitani, Kiyoaki Inoue, Yuichi Noguchi, Toshio Hosaka, Hitoshi Ishida, Shigehiro Katayama,
published by
Journal of Diabetes Mellitus,
Vol.4 No.3, 2014
has been cited by the following article(s):
|
[1]
|
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
Diabetes, Obesity and Metabolism,
2018
DOI:10.1111/dom.13082
|
|
|
|
|
[2]
|
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
Diabetes, Obesity and Metabolism,
2017
DOI:10.1111/dom.13082
|
|
|
|